カテゴリー： Market Monitor Global, 世界, 医療/バイオ

バイオ医薬品凝集解析装置の世界市場見通し2023年-2029年

◆英語タイトル：Biopharmaceutical Aggregation Analysis System Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5101）

◆商品コード：MMG23JU5101
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月（※2025年版があります。お問い合わせください。）
◆ページ数：70
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Biopharmaceutical Aggregation Analysis System Market 調査レポートは次の情報を含め、グローバルにおけるのバイオ医薬品凝集解析装置市場規模と予測を収録しています。・世界のバイオ医薬品凝集解析装置市場：売上、2018年-2023年、2024年-2029年
・世界のバイオ医薬品凝集解析装置市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のバイオ医薬品凝集解析装置市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ナノメートル（<100nm）」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

バイオ医薬品凝集解析装置のグローバル主要企業は、Shimadzu、 Thermo Fisher Scientific、 Malvern Panalytical、 Agilent Technologies、 HORIBA、 ProteinSimple、 Creative Biolabs、 Beckman Coulter、 Brukerなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、バイオ医薬品凝集解析装置のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のバイオ医薬品凝集解析装置市場：タイプ別、2018年-2023年、2024年-2029年
世界のバイオ医薬品凝集解析装置市場：タイプ別市場シェア、2022年
・ナノメートル（<100nm）、サブミクロン（100nm-1μm）、可視（1-100μm）、可視（>100μm）

世界のバイオ医薬品凝集解析装置市場：用途別、2018年-2023年、2024年-2029年
世界のバイオ医薬品凝集解析装置市場：用途別市場シェア、2022年
・バイオ薬局、研究所、その他

世界のバイオ医薬品凝集解析装置市場：地域・国別、2018年-2023年、2024年-2029年
世界のバイオ医薬品凝集解析装置市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるバイオ医薬品凝集解析装置のグローバル売上、2018年-2023年
・主要企業におけるバイオ医薬品凝集解析装置のグローバル売上シェア、2022年
・主要企業におけるバイオ医薬品凝集解析装置のグローバル販売量、2018年-2023年
・主要企業におけるバイオ医薬品凝集解析装置のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Shimadzu、 Thermo Fisher Scientific、 Malvern Panalytical、 Agilent Technologies、 HORIBA、 ProteinSimple、 Creative Biolabs、 Beckman Coulter、 Bruker

*************************************************************

・調査・分析レポートの概要
バイオ医薬品凝集解析装置市場の定義
市場セグメント
世界のバイオ医薬品凝集解析装置市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のバイオ医薬品凝集解析装置市場規模
世界のバイオ医薬品凝集解析装置市場規模：2022年 VS 2029年
世界のバイオ医薬品凝集解析装置市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのバイオ医薬品凝集解析装置の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のバイオ医薬品凝集解析装置製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ナノメートル（<100nm）、サブミクロン（100nm-1μm）、可視（1-100μm）、可視（>100μm）
バイオ医薬品凝集解析装置のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：バイオ薬局、研究所、その他
バイオ医薬品凝集解析装置の用途別グローバル売上・予測

・地域別市場分析
地域別バイオ医薬品凝集解析装置市場規模 2022年と2029年
地域別バイオ医薬品凝集解析装置売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Shimadzu、 Thermo Fisher Scientific、 Malvern Panalytical、 Agilent Technologies、 HORIBA、 ProteinSimple、 Creative Biolabs、 Beckman Coulter、 Bruker
...

The Biopharmaceutical Aggregation Analysis System can quantitatively evaluate the amount of particles in the range of 0.1 μm to 10 μm as concentration (unit: μg/mL or particles/mL). Aggregates of biopharmaceuticals can be classified into several ranges based on particle size: nanometer (<100 nm), submicron (100 nm to 1 μm), subvisible (1 to 100 μm), and visible (>100 μm).
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Aggregation Analysis System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Aggregation Analysis System. This report contains market size and forecasts of Biopharmaceutical Aggregation Analysis System in global, including the following market information:
Global Biopharmaceutical Aggregation Analysis System Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Biopharmaceutical Aggregation Analysis System Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Biopharmaceutical Aggregation Analysis System companies in 2022 (%)
The global Biopharmaceutical Aggregation Analysis System market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Nanometer (<100 nm) Segment to Reach $ Million by 2029, with a % CAGR in next six years. The global key manufacturers of Biopharmaceutical Aggregation Analysis System include Shimadzu, Thermo Fisher Scientific, Malvern Panalytical, Agilent Technologies, HORIBA, ProteinSimple, Creative Biolabs, Beckman Coulter and Bruker, etc. in 2022, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biopharmaceutical Aggregation Analysis System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Biopharmaceutical Aggregation Analysis System Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units) Global Biopharmaceutical Aggregation Analysis System Market Segment Percentages, by Type, 2022 (%) Nanometer (<100 nm) Submicron (100 nm to 1 μm) Subvisible (1 to 100 μm) Visible (>100 μm)
Global Biopharmaceutical Aggregation Analysis System Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biopharmaceutical Aggregation Analysis System Market Segment Percentages, by Application, 2022 (%)
Bio-pharmacy
Laboratory
Others
Global Biopharmaceutical Aggregation Analysis System Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biopharmaceutical Aggregation Analysis System Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biopharmaceutical Aggregation Analysis System revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Biopharmaceutical Aggregation Analysis System revenues share in global market, 2022 (%)
Key companies Biopharmaceutical Aggregation Analysis System sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Biopharmaceutical Aggregation Analysis System sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Shimadzu
Thermo Fisher Scientific
Malvern Panalytical
Agilent Technologies
HORIBA
ProteinSimple
Creative Biolabs
Beckman Coulter
Bruker
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biopharmaceutical Aggregation Analysis System, market overview.
Chapter 2: Global Biopharmaceutical Aggregation Analysis System market size in revenue and volume.
Chapter 3: Detailed analysis of Biopharmaceutical Aggregation Analysis System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biopharmaceutical Aggregation Analysis System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biopharmaceutical Aggregation Analysis System capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Biopharmaceutical Aggregation Analysis System Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biopharmaceutical Aggregation Analysis System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biopharmaceutical Aggregation Analysis System Overall Market Size
2.1 Global Biopharmaceutical Aggregation Analysis System Market Size: 2022 VS 2029
2.2 Global Biopharmaceutical Aggregation Analysis System Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Biopharmaceutical Aggregation Analysis System Sales: 2018-2029
3 Company Landscape
3.1 Top Biopharmaceutical Aggregation Analysis System Players in Global Market
3.2 Top Global Biopharmaceutical Aggregation Analysis System Companies Ranked by Revenue
3.3 Global Biopharmaceutical Aggregation Analysis System Revenue by Companies
3.4 Global Biopharmaceutical Aggregation Analysis System Sales by Companies
3.5 Global Biopharmaceutical Aggregation Analysis System Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Biopharmaceutical Aggregation Analysis System Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Biopharmaceutical Aggregation Analysis System Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biopharmaceutical Aggregation Analysis System Players in Global Market
3.8.1 List of Global Tier 1 Biopharmaceutical Aggregation Analysis System Companies
3.8.2 List of Global Tier 2 and Tier 3 Biopharmaceutical Aggregation Analysis System Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Biopharmaceutical Aggregation Analysis System Market Size Markets, 2022 & 2029
4.1.2 Nanometer (<100 nm) 4.1.3 Submicron (100 nm to 1 μm) 4.1.4 Subvisible (1 to 100 μm) 4.1.5 Visible (>100 μm)
4.2 By Type – Global Biopharmaceutical Aggregation Analysis System Revenue & Forecasts
4.2.1 By Type – Global Biopharmaceutical Aggregation Analysis System Revenue, 2018-2023
4.2.2 By Type – Global Biopharmaceutical Aggregation Analysis System Revenue, 2024-2029
4.2.3 By Type – Global Biopharmaceutical Aggregation Analysis System Revenue Market Share, 2018-2029
4.3 By Type – Global Biopharmaceutical Aggregation Analysis System Sales & Forecasts
4.3.1 By Type – Global Biopharmaceutical Aggregation Analysis System Sales, 2018-2023
4.3.2 By Type – Global Biopharmaceutical Aggregation Analysis System Sales, 2024-2029
4.3.3 By Type – Global Biopharmaceutical Aggregation Analysis System Sales Market Share, 2018-2029
4.4 By Type – Global Biopharmaceutical Aggregation Analysis System Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Biopharmaceutical Aggregation Analysis System Market Size, 2022 & 2029
5.1.2 Bio-pharmacy
5.1.3 Laboratory
5.1.4 Others
5.2 By Application – Global Biopharmaceutical Aggregation Analysis System Revenue & Forecasts
5.2.1 By Application – Global Biopharmaceutical Aggregation Analysis System Revenue, 2018-2023
5.2.2 By Application – Global Biopharmaceutical Aggregation Analysis System Revenue, 2024-2029
5.2.3 By Application – Global Biopharmaceutical Aggregation Analysis System Revenue Market Share, 2018-2029
5.3 By Application – Global Biopharmaceutical Aggregation Analysis System Sales & Forecasts
5.3.1 By Application – Global Biopharmaceutical Aggregation Analysis System Sales, 2018-2023
5.3.2 By Application – Global Biopharmaceutical Aggregation Analysis System Sales, 2024-2029
5.3.3 By Application – Global Biopharmaceutical Aggregation Analysis System Sales Market Share, 2018-2029
5.4 By Application – Global Biopharmaceutical Aggregation Analysis System Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Biopharmaceutical Aggregation Analysis System Market Size, 2022 & 2029
6.2 By Region – Global Biopharmaceutical Aggregation Analysis System Revenue & Forecasts
6.2.1 By Region – Global Biopharmaceutical Aggregation Analysis System Revenue, 2018-2023
6.2.2 By Region – Global Biopharmaceutical Aggregation Analysis System Revenue, 2024-2029
6.2.3 By Region – Global Biopharmaceutical Aggregation Analysis System Revenue Market Share, 2018-2029
6.3 By Region – Global Biopharmaceutical Aggregation Analysis System Sales & Forecasts
6.3.1 By Region – Global Biopharmaceutical Aggregation Analysis System Sales, 2018-2023
6.3.2 By Region – Global Biopharmaceutical Aggregation Analysis System Sales, 2024-2029
6.3.3 By Region – Global Biopharmaceutical Aggregation Analysis System Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Biopharmaceutical Aggregation Analysis System Revenue, 2018-2029
6.4.2 By Country – North America Biopharmaceutical Aggregation Analysis System Sales, 2018-2029
6.4.3 US Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
6.4.4 Canada Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
6.4.5 Mexico Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Biopharmaceutical Aggregation Analysis System Revenue, 2018-2029
6.5.2 By Country – Europe Biopharmaceutical Aggregation Analysis System Sales, 2018-2029
6.5.3 Germany Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
6.5.4 France Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
6.5.5 U.K. Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
6.5.6 Italy Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
6.5.7 Russia Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
6.5.8 Nordic Countries Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
6.5.9 Benelux Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Biopharmaceutical Aggregation Analysis System Revenue, 2018-2029
6.6.2 By Region – Asia Biopharmaceutical Aggregation Analysis System Sales, 2018-2029
6.6.3 China Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
6.6.4 Japan Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
6.6.5 South Korea Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
6.6.6 Southeast Asia Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
6.6.7 India Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Biopharmaceutical Aggregation Analysis System Revenue, 2018-2029
6.7.2 By Country – South America Biopharmaceutical Aggregation Analysis System Sales, 2018-2029
6.7.3 Brazil Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
6.7.4 Argentina Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Biopharmaceutical Aggregation Analysis System Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Biopharmaceutical Aggregation Analysis System Sales, 2018-2029
6.8.3 Turkey Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
6.8.4 Israel Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
6.8.5 Saudi Arabia Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
6.8.6 UAE Biopharmaceutical Aggregation Analysis System Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Shimadzu
7.1.1 Shimadzu Company Summary
7.1.2 Shimadzu Business Overview
7.1.3 Shimadzu Biopharmaceutical Aggregation Analysis System Major Product Offerings
7.1.4 Shimadzu Biopharmaceutical Aggregation Analysis System Sales and Revenue in Global (2018-2023)
7.1.5 Shimadzu Key News & Latest Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Biopharmaceutical Aggregation Analysis System Major Product Offerings
7.2.4 Thermo Fisher Scientific Biopharmaceutical Aggregation Analysis System Sales and Revenue in Global (2018-2023)
7.2.5 Thermo Fisher Scientific Key News & Latest Developments
7.3 Malvern Panalytical
7.3.1 Malvern Panalytical Company Summary
7.3.2 Malvern Panalytical Business Overview
7.3.3 Malvern Panalytical Biopharmaceutical Aggregation Analysis System Major Product Offerings
7.3.4 Malvern Panalytical Biopharmaceutical Aggregation Analysis System Sales and Revenue in Global (2018-2023)
7.3.5 Malvern Panalytical Key News & Latest Developments
7.4 Agilent Technologies
7.4.1 Agilent Technologies Company Summary
7.4.2 Agilent Technologies Business Overview
7.4.3 Agilent Technologies Biopharmaceutical Aggregation Analysis System Major Product Offerings
7.4.4 Agilent Technologies Biopharmaceutical Aggregation Analysis System Sales and Revenue in Global (2018-2023)
7.4.5 Agilent Technologies Key News & Latest Developments
7.5 HORIBA
7.5.1 HORIBA Company Summary
7.5.2 HORIBA Business Overview
7.5.3 HORIBA Biopharmaceutical Aggregation Analysis System Major Product Offerings
7.5.4 HORIBA Biopharmaceutical Aggregation Analysis System Sales and Revenue in Global (2018-2023)
7.5.5 HORIBA Key News & Latest Developments
7.6 ProteinSimple
7.6.1 ProteinSimple Company Summary
7.6.2 ProteinSimple Business Overview
7.6.3 ProteinSimple Biopharmaceutical Aggregation Analysis System Major Product Offerings
7.6.4 ProteinSimple Biopharmaceutical Aggregation Analysis System Sales and Revenue in Global (2018-2023)
7.6.5 ProteinSimple Key News & Latest Developments
7.7 Creative Biolabs
7.7.1 Creative Biolabs Company Summary
7.7.2 Creative Biolabs Business Overview
7.7.3 Creative Biolabs Biopharmaceutical Aggregation Analysis System Major Product Offerings
7.7.4 Creative Biolabs Biopharmaceutical Aggregation Analysis System Sales and Revenue in Global (2018-2023)
7.7.5 Creative Biolabs Key News & Latest Developments
7.8 Beckman Coulter
7.8.1 Beckman Coulter Company Summary
7.8.2 Beckman Coulter Business Overview
7.8.3 Beckman Coulter Biopharmaceutical Aggregation Analysis System Major Product Offerings
7.8.4 Beckman Coulter Biopharmaceutical Aggregation Analysis System Sales and Revenue in Global (2018-2023)
7.8.5 Beckman Coulter Key News & Latest Developments
7.9 Bruker
7.9.1 Bruker Company Summary
7.9.2 Bruker Business Overview
7.9.3 Bruker Biopharmaceutical Aggregation Analysis System Major Product Offerings
7.9.4 Bruker Biopharmaceutical Aggregation Analysis System Sales and Revenue in Global (2018-2023)
7.9.5 Bruker Key News & Latest Developments
8 Global Biopharmaceutical Aggregation Analysis System Production Capacity, Analysis
8.1 Global Biopharmaceutical Aggregation Analysis System Production Capacity, 2018-2029
8.2 Biopharmaceutical Aggregation Analysis System Production Capacity of Key Manufacturers in Global Market
8.3 Global Biopharmaceutical Aggregation Analysis System Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biopharmaceutical Aggregation Analysis System Supply Chain Analysis
10.1 Biopharmaceutical Aggregation Analysis System Industry Value Chain
10.2 Biopharmaceutical Aggregation Analysis System Upstream Market
10.3 Biopharmaceutical Aggregation Analysis System Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biopharmaceutical Aggregation Analysis System Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Biopharmaceutical Aggregation Analysis System in Global Market
Table 2. Top Biopharmaceutical Aggregation Analysis System Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Biopharmaceutical Aggregation Analysis System Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Biopharmaceutical Aggregation Analysis System Revenue Share by Companies, 2018-2023
Table 5. Global Biopharmaceutical Aggregation Analysis System Sales by Companies, (K Units), 2018-2023
Table 6. Global Biopharmaceutical Aggregation Analysis System Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Biopharmaceutical Aggregation Analysis System Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Biopharmaceutical Aggregation Analysis System Product Type
Table 9. List of Global Tier 1 Biopharmaceutical Aggregation Analysis System Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biopharmaceutical Aggregation Analysis System Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Biopharmaceutical Aggregation Analysis System Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Biopharmaceutical Aggregation Analysis System Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Biopharmaceutical Aggregation Analysis System Sales (K Units), 2018-2023
Table 15. By Type - Global Biopharmaceutical Aggregation Analysis System Sales (K Units), 2024-2029
Table 16. By Application – Global Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Biopharmaceutical Aggregation Analysis System Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Biopharmaceutical Aggregation Analysis System Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Biopharmaceutical Aggregation Analysis System Sales (K Units), 2018-2023
Table 20. By Application - Global Biopharmaceutical Aggregation Analysis System Sales (K Units), 2024-2029
Table 21. By Region – Global Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Biopharmaceutical Aggregation Analysis System Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Biopharmaceutical Aggregation Analysis System Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Biopharmaceutical Aggregation Analysis System Sales (K Units), 2018-2023
Table 25. By Region - Global Biopharmaceutical Aggregation Analysis System Sales (K Units), 2024-2029
Table 26. By Country - North America Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Biopharmaceutical Aggregation Analysis System Sales, (K Units), 2018-2023
Table 29. By Country - North America Biopharmaceutical Aggregation Analysis System Sales, (K Units), 2024-2029
Table 30. By Country - Europe Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Biopharmaceutical Aggregation Analysis System Sales, (K Units), 2018-2023
Table 33. By Country - Europe Biopharmaceutical Aggregation Analysis System Sales, (K Units), 2024-2029
Table 34. By Region - Asia Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Biopharmaceutical Aggregation Analysis System Sales, (K Units), 2018-2023
Table 37. By Region - Asia Biopharmaceutical Aggregation Analysis System Sales, (K Units), 2024-2029
Table 38. By Country - South America Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Biopharmaceutical Aggregation Analysis System Sales, (K Units), 2018-2023
Table 41. By Country - South America Biopharmaceutical Aggregation Analysis System Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Biopharmaceutical Aggregation Analysis System Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Biopharmaceutical Aggregation Analysis System Sales, (K Units), 2024-2029
Table 46. Shimadzu Company Summary
Table 47. Shimadzu Biopharmaceutical Aggregation Analysis System Product Offerings
Table 48. Shimadzu Biopharmaceutical Aggregation Analysis System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Shimadzu Key News & Latest Developments
Table 50. Thermo Fisher Scientific Company Summary
Table 51. Thermo Fisher Scientific Biopharmaceutical Aggregation Analysis System Product Offerings
Table 52. Thermo Fisher Scientific Biopharmaceutical Aggregation Analysis System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Thermo Fisher Scientific Key News & Latest Developments
Table 54. Malvern Panalytical Company Summary
Table 55. Malvern Panalytical Biopharmaceutical Aggregation Analysis System Product Offerings
Table 56. Malvern Panalytical Biopharmaceutical Aggregation Analysis System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Malvern Panalytical Key News & Latest Developments
Table 58. Agilent Technologies Company Summary
Table 59. Agilent Technologies Biopharmaceutical Aggregation Analysis System Product Offerings
Table 60. Agilent Technologies Biopharmaceutical Aggregation Analysis System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Agilent Technologies Key News & Latest Developments
Table 62. HORIBA Company Summary
Table 63. HORIBA Biopharmaceutical Aggregation Analysis System Product Offerings
Table 64. HORIBA Biopharmaceutical Aggregation Analysis System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. HORIBA Key News & Latest Developments
Table 66. ProteinSimple Company Summary
Table 67. ProteinSimple Biopharmaceutical Aggregation Analysis System Product Offerings
Table 68. ProteinSimple Biopharmaceutical Aggregation Analysis System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. ProteinSimple Key News & Latest Developments
Table 70. Creative Biolabs Company Summary
Table 71. Creative Biolabs Biopharmaceutical Aggregation Analysis System Product Offerings
Table 72. Creative Biolabs Biopharmaceutical Aggregation Analysis System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Creative Biolabs Key News & Latest Developments
Table 74. Beckman Coulter Company Summary
Table 75. Beckman Coulter Biopharmaceutical Aggregation Analysis System Product Offerings
Table 76. Beckman Coulter Biopharmaceutical Aggregation Analysis System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Beckman Coulter Key News & Latest Developments
Table 78. Bruker Company Summary
Table 79. Bruker Biopharmaceutical Aggregation Analysis System Product Offerings
Table 80. Bruker Biopharmaceutical Aggregation Analysis System Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Bruker Key News & Latest Developments
Table 82. Biopharmaceutical Aggregation Analysis System Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Biopharmaceutical Aggregation Analysis System Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Biopharmaceutical Aggregation Analysis System Production by Region, 2018-2023 (K Units)
Table 85. Global Biopharmaceutical Aggregation Analysis System Production by Region, 2024-2029 (K Units)
Table 86. Biopharmaceutical Aggregation Analysis System Market Opportunities & Trends in Global Market
Table 87. Biopharmaceutical Aggregation Analysis System Market Drivers in Global Market
Table 88. Biopharmaceutical Aggregation Analysis System Market Restraints in Global Market
Table 89. Biopharmaceutical Aggregation Analysis System Raw Materials
Table 90. Biopharmaceutical Aggregation Analysis System Raw Materials Suppliers in Global Market
Table 91. Typical Biopharmaceutical Aggregation Analysis System Downstream
Table 92. Biopharmaceutical Aggregation Analysis System Downstream Clients in Global Market
Table 93. Biopharmaceutical Aggregation Analysis System Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biopharmaceutical Aggregation Analysis System Segment by Type in 2022
Figure 2. Biopharmaceutical Aggregation Analysis System Segment by Application in 2022
Figure 3. Global Biopharmaceutical Aggregation Analysis System Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biopharmaceutical Aggregation Analysis System Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Biopharmaceutical Aggregation Analysis System Revenue, 2018-2029 (US$, Mn)
Figure 7. Biopharmaceutical Aggregation Analysis System Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Biopharmaceutical Aggregation Analysis System Revenue in 2022
Figure 9. By Type - Global Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Biopharmaceutical Aggregation Analysis System Revenue Market Share, 2018-2029
Figure 11. By Type - Global Biopharmaceutical Aggregation Analysis System Sales Market Share, 2018-2029
Figure 12. By Type - Global Biopharmaceutical Aggregation Analysis System Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Biopharmaceutical Aggregation Analysis System Revenue Market Share, 2018-2029
Figure 15. By Application - Global Biopharmaceutical Aggregation Analysis System Sales Market Share, 2018-2029
Figure 16. By Application - Global Biopharmaceutical Aggregation Analysis System Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Biopharmaceutical Aggregation Analysis System Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Biopharmaceutical Aggregation Analysis System Revenue Market Share, 2018-2029
Figure 20. By Region - Global Biopharmaceutical Aggregation Analysis System Sales Market Share, 2018-2029
Figure 21. By Country - North America Biopharmaceutical Aggregation Analysis System Revenue Market Share, 2018-2029
Figure 22. By Country - North America Biopharmaceutical Aggregation Analysis System Sales Market Share, 2018-2029
Figure 23. US Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Biopharmaceutical Aggregation Analysis System Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Biopharmaceutical Aggregation Analysis System Sales Market Share, 2018-2029
Figure 28. Germany Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 29. France Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Biopharmaceutical Aggregation Analysis System Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Biopharmaceutical Aggregation Analysis System Sales Market Share, 2018-2029
Figure 37. China Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 41. India Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Biopharmaceutical Aggregation Analysis System Revenue Market Share, 2018-2029
Figure 43. By Country - South America Biopharmaceutical Aggregation Analysis System Sales Market Share, 2018-2029
Figure 44. Brazil Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Biopharmaceutical Aggregation Analysis System Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Biopharmaceutical Aggregation Analysis System Sales Market Share, 2018-2029
Figure 48. Turkey Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Biopharmaceutical Aggregation Analysis System Revenue, (US$, Mn), 2018-2029
Figure 52. Global Biopharmaceutical Aggregation Analysis System Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Biopharmaceutical Aggregation Analysis System by Region, 2022 VS 2029
Figure 54. Biopharmaceutical Aggregation Analysis System Industry Value Chain
Figure 55. Marketing Channels

※参考情報

バイオ医薬品凝集解析装置は、バイオ医薬品の効力と安全性を評価する上で重要な役割を果たしています。バイオ医薬品は生物由来で製造される薬剤であり、特に抗体医薬品やワクチンにおいては、凝集形成が製剤の品質や効果に大きな影響を与えることが知られています。そのため、凝集の解析は製品の開発過程や製造プロセスの管理において欠かせないステップとなっています。

まず、バイオ医薬品凝集解析装置の定義について考えてみましょう。この装置は、バイオ医薬品におけるタンパク質の凝集状態やその特性を評価するための専門的な装置です。凝集は、タンパク質の構造や機能に重大な影響を及ぼす可能性があり、その結果、製品の有効性や安全性が損なわれる恐れがあります。したがって、これらの装置は、製剤の品質管理や開発における必須のツールとして位置づけられています。

次に、バイオ医薬品凝集解析装置の特徴について述べます。これらの装置は、通常、高感度かつ高精度の測定が可能です。これにより、微細な凝集体の検出が行え、さらにそのサイズや濃度、形状を解析することが可能となります。さらに、これらの装置は、リアルタイムでの分析が可能であり、製造プロセスの最適化やトラブルシューティングにも貢献します。また、さまざまな測定原理が適用されており、光散乱、動的光散乱、ナノ粒子追跡分析（NTA）、透過型電子顕微鏡（TEM）などが一般的に使用されています。

種類としては、バイオ医薬品凝集解析装置にはいくつかのタイプがあります。まず、標準的な光散乱装置が挙げられます。これは、粒子のサイズや濃度を測定するために広く用いられています。次に、動的光散乱（DLS）装置は、小さな凝集体や粒子の動きを分析し、それによるサイズ推定を行います。これに対して、静的光散乱（SLS）装置は、より大きな粒子に対する情報を提供します。また、ナノ粒子追跡分析（NTA）は、特にナノサイズの粒子を高精度で分析することができ、バイオ医薬品の開発において重要な技術とされています。

さらに、透過型電子顕微鏡（TEM）は、高い解像度で凝集体の形状や構造を直接観察することができるため、補完的な手法として多くの研究に用いられています。このように、さまざまな分析手法を組み合わせることで、バイオ医薬品の凝集状態をより正確に把握することが可能となります。

バイオ医薬品凝集解析装置の用途について考えると、まず製薬業界における品質管理が挙げられます。製剤の開発段階では、凝集の形成がどのように影響するのかを事前に評価することが重要です。これにより、効力が低下したり、さらには副作用が引き起こされるリスクを低減できます。また、製造プロセス中におけるリアルタイムモニタリングも可能であり、製品の一貫性を保つために重要です。

次に、臨床研究や前臨床試験においても、これらの装置は重要なツールとされています。バイオ医薬品の臨床試験においては、製品の安定性や作用機序に関する情報を提供することが求められます。凝集解析は、投与後の薬剤の挙動を理解し、適切な投与量や投与方法を決定する上で非常に重要です。

関連技術について触れると、バイオ分析技術やマススペクトロメトリー（MS）にも注目が集まっています。これらの技術は、凝集とは異なる側面からバイオ医薬品の特性を明らかにします。たとえば、マススペクトロメトリーは、タンパク質の分子量やその構造の変化を解明するために用いられ、凝集形成のメカニズムを理解するために役立つことがあります。

さらに、コンピュータシミュレーション技術の進展により、凝集形成の予測モデルの構築が可能になっています。これにより、実験的な解析だけでなく、数理モデルを通じて凝集挙動の予測ができるようになり、開発プロセスの効率化に寄与することが期待されています。

以上のように、バイオ医薬品凝集解析装置は、バイオ医薬品の品質管理や開発において欠かせない存在となっています。凝集の解析は製品の有効性や安全性を確保するために非常に重要であり、関連する技術と合わせて今後の研究開発においてますます重要な役割を果たすことでしょう。各種の技術の進展により、より高性能な解析が可能となり、バイオ医薬品の製造と使用における信頼性の向上が期待されています。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ バイオ医薬品凝集解析装置の世界市場見通し2023年-2029年(Biopharmaceutical Aggregation Analysis System Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

バイオ医薬品凝集解析装置の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp